Through Wyeth Australia, Wyeth manufactures and sells its extended release formulation of venlafaxine hydrochloride under the name Efexor-XR . The references to "formulation" in the claims thus must exclude hydrogel tablet technology. Alphapharm is Australia's largest generic supplier, which supports an inference of a large product range. It provides no good reason to infer that Alphapharm could not have acted earlier. Competing submissions Alphapharm relied on Dr Rowe's evidence (referred to at [85] above) to support its argument that the alleged invention in the method patent did not involve any inventive step.